Chemical Name: 3-(S)-(+)-(1-carbamoyl-1,1-diphenyl methyl)pyrrolidine
Development and validation of RP-UPLC method for the determination of darifenacin hydrobromide, its related compounds and its degradation products using design of experiments
M. Vishnu Murthya,b,∗, Ch. Krishnaiaha, K. Srinivas a, K. Srinivasa Raoa, N. Ramesh Kumar a, K. Mukkanti b
Journal of Pharmaceutical and Biomedical Analysis 72 (2013) 40–50
A New Solvent System (Cyclopentyl Methyl Ether−Water) in Process Development of Darifenacin HBr
Chinmoy Pramanik,* Kiran Bapat, Ashok Chaudhari, Narendra K. Tripathy,* and Mukund K. Gurjar
Org. Process Res. Dev. 2012, 16, 1591−1597
Identification, isolation and characterization of dimer impurities in antimuscarinic agent darifenacin hydrobromide
P. Badarinadh Gupta1,2,*, B. Venkateswara Rao2 , S. Paul Douglas2 , Hemant Kumar Sharma1 and D. Vijaya Bharathi
World Journal of Pharmaceutical Research Volume 6, Issue 6, 1041-1063
A stereoselective,stability indicating validated LC-assay method for the separation and quantification of darifenacin and its enantiomer
M.Vishnu Murthy 1,2*, K.S.V.Raghavacharyulu 1 , Ch.Krishnaiah 1 , Katkam Srinivas 1 , K.Mukkanti2 , N.Ramesh Kumar
ACAIJ, 8(1) 2009 [87-93]
